Fulcrum therapeutics to participate at the upcoming bofa securities 2022 healthcare conference

Cambridge, mass., may 05, 2022 (globe newswire) -- fulcrum therapeutics, inc. ®  (nasdaq: fulc), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will participate in a fireside chat at the bofa securities 2022 healthcare conference, on thursday, may 12, 2022 at 11:20 a.m. pt (2:20 p.m. et).
FULC Ratings Summary
FULC Quant Ranking